Natasha Savoie - Concepedia

Author

Natasha Savoie

United States Food and Drug Administration

Also Known As

Natasha Savoie

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration Pfizer (United States)Bristol-Myers Squibb (United States)Health Canada GlaxoSmithKline (United States)

About

Natasha Savoie is an author at United States Food and Drug Administration specializing in bioanalysis, medicine, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	569
2	Engineering	11	11	416
3	Allergy	2	2	78
4	Natural Sciences	1	1	65
5	Public Health	1	1	88

Natasha Savoie

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
2010 White Paper on Recent Issues in Regulated Bioanalysis & Global Harmonization of Bioanalytical Guidance Natasha Savoie, Fabio Garofolo, Peter van Amsterdam, Bioanalysis EngineeringWhite PaperValidation Group WorkshopBioanalysisAnalytical Chemistry	2010	122
The 2nd Calibration and Validation Group Workshop on Recent Issues in Good Laboratory Practice Bioanalysis Natasha Savoie, Brian Booth, T Hyman Bradley, Bioanalysis EngineeringMeasurementBioanalytical DataValidation Group WorkshopAnalytical Instrumentation	2009	94
Recommendations On: Internal Standard Criteria, Stability, Incurred Sample Reanalysis and Recent 483s by the Global CRO Council for Bioanalysis Steve Lowes, Jim Jersey, Ronald E. Shoup, Bioanalysis Global Cro CouncilMedicineGlobal HealthBioanalysisBiotechnology	2011	88
2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 3 – Lba, Biomarkers and Immunogenicity) Lakshmi Amaravadi, An Song, Heather Myler, Bioanalysis	2015	74
2017 White Paper on Recent Issues in Bioanalysis: A Global Perspective on Immunogenicity Guidelines & Biomarker Assay Performance (Part 3 – Lba: Immunogenicity, Biomarkers and PK Assays) Shalini Gupta, Susan Richards, Lakshmi Amaravadi, Bioanalysis ImmunohematologyPk AssaysWhite PaperImmunologyBiological Mass Spectrometry	2017	65
2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation ( <u>Part 3</u> –Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene & Cell Therapy and Vaccine Assays) Bart Corsaro, Tong‐Yuan Yang, Rocio Murphy, Bioanalysis	2021	60
2016 White Paper on Recent Issues in Bioanalysis: Focus on Biomarker Assay Validation (BAV): (Part 3 – Lba, Biomarkers and Immunogenicity) Susan Richards, Lakshmi Amaravadi, Renuka Pillutla, Bioanalysis EngineeringWhite PaperImmunologyBiological Mass SpectrometryPathology	2016	58
2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 2 – Hybrid LBA/LCMS and Input from Regulatory Agencies) Brad Ackermann, Hendrik Neubert, Nicola Hughes, Bioanalysis	2015	55
2016 White Paper on Recent Issues in Bioanalysis: Focus on Biomarker Assay Validation (BAV) (Part 1 – Small Molecules, Peptides and Small Molecule Biomarkers by LCMS) Eric Yang, Jan Welink, Stephanie Cape, Bioanalysis	2016	48
The Decennial Index of The White Papers in Bioanalysis: <i>‘A Decade of Recommendations (2007–2016)’</i> Wei Garofolo, Natasha Savoie Bioanalysis Decennial IndexA DecadeScientific IntegrityBibliometricsBiostatistics	2017	45

Page 1